Article

Solitary subependymal giant cell astrocytoma incidentally found at autopsy in an elderly woman without tuberous sclerosis complex.

Department of Pathology, The Methodist Hospital, Houston, Texas 77030, USA.
Neuropathology (Impact Factor: 1.8). 08/2008; 29(2):181-6. DOI: 10.1111/j.1440-1789.2008.00941.x
Source: PubMed

ABSTRACT Subependymal giant cell astrocytoma (SEGA) is a benign, slowly growing tumor typically occurring in the setting of tuberous sclerosis complex (TSC). However there are several reported cases in which patients with a solitary SEGA had no other stigmata of TSC. We describe a case of SEGA in a 75-year-old woman representing the oldest patient reported to-date. The patient had a history of radical vulvectomy for malignant melanoma (MM), and died of autopsy-confirmed widespread systemic metastasis. Postmortem examination of the brain revealed a single 2.1 x 1.0 x 0.8 cm intraventricular nodule in the lateral ventricle. Histologically, it was composed of interlacing bundles of spindle-shaped tumor cells with thin delicate processes admixed with relatively large pleomorphic cells with abundant glassy eosinophilic cytoplasm, as seen in a SEGA. Immunohistochemically, GFAP, S-100 protein, and neuron specific enolase were positive, and synaptophysin labeled a few tumor cells. Also noted were rare isolated MM cells within the tumor (i.e., tumor-to-tumor metastasis). Autopsy showed no manifestations of TSC systemically or intracranially. The histopathological differential diagnosis was limited and included giant cell ependymoma and, much less likely, giant cell glioblastoma and pleomorphic xanthoastrocytoma. This case illustrates that SEGA can be found incidentally in an elderly individual with no associated symptoms and also indicates that SEGA can occur outside the setting of TSC. Tumor metastasis to an occult SEGA is extremely rare.

0 Followers
 · 
74 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: La codélétion des bras chromosomiques 1p et 19q, correspondant à une translocation réciproque déséquilibrée t(1;19)(q10;p10), est observée dans les tumeurs oligodendrogliales et est associée à un meilleur pronostic et à une meilleure réponse à la chimiothérapie. Les altérations deBRAF sont rapportées dans les astrocytomes pilocytiques (duplication en tandem-réarrangement) et dans les xanthoastrocytomes pléomorphes (mutation BRAF V600E). La très grande majorité des glioblastomes primaires oude novoont des altérations génétiques dérégulant les voies de signalisation intracellulaires : des récepteurs transmembranaires aux facteurs de croissance et à activité tyrosine kinase et les voies de signalisation d’aval (i.e. NF1-RAS-RAF-MAPK et PTEN-PI3K-AKT-TSC-mTOR) ; de RB ; et de TP53. Les mutations des gènesIDH1/IDH2 sont fréquentes dans les gliomes diffus de grade II et de grade III et dans les glioblastomes secondaires. Elles constituent un biomarqueur diagnostique et pronostique favorable indépendant. En revanche, elles sont rares dans les glioblastomes primaires oude novoet absentes dans les astrocytomes pilocytiques. Les mutations germinales des gènesMSH2/MLH1/PMS2/MSH6,CDKN2A,TSC1/TSC2,PTEN,TP53 etNF1/NF2 prédisposent aux tumeurs gliales dans le cadre des syndromes de prédisposition héréditaires aux cancers. Des polymorphismes de simple base des gènesTERT,CCDC26,CDKN2A/CDKN2B,RTEL, EGFRetPHLDB1 confèrent une susceptibilité héréditaire aux tumeurs gliales.
    La Presse Médicale 05/2013; 42(5):806–813. DOI:10.1016/j.lpm.2012.05.013 · 1.17 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Over the past decade, there have been numerous advances in our understanding of the molecular pathogenesis of tuberous sclerosis complex (TSC). Following the identification of the TSC1 and TSC2 genes, a link to regulatory control of the mammalian target of rapamycin (mTOR) signaling pathway has paved the way for new therapeutic interventions, and now even approved therapies for TSC. Gene identification has permitted establishment of cell lines and conditional knockout mouse strains to assay how abnormalities in brain structure lead to enhanced excitability, seizures, cognitive disabilities, and other neuropsychological disorders in TSC. Furthermore, work in in vitro systems and analysis of rodent models and human tissue has allowed investigators to study how brain lesions form in TSC. Evolving questions over the next decade include understanding the high clinical variability of TSC, defining why there is a lack of clear genotype-phenotype correlations, and identifying biomarkers for prognosis and stratification. The study of TSC has in many ways reflected a paradigm "bench-to-bedside" success story that serves as a model of many other neurological disorders.
    Acta Neuropathologica 02/2013; 125(3). DOI:10.1007/s00401-013-1085-x · 9.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A variety of neoplasms may arise in the ventricular system. Intraventricular neoplasms may be discovered as an incidental finding at cross-sectional imaging or may manifest with varied symptoms depending on their location, including symptoms of increased intracranial pressure. These lesions may arise from various ventricular structures, including the ependymal lining (eg, ependymoma), subependymal layer (eg, subependymoma), or choroid plexus (eg, choroid plexus neoplasms), or they may have a cell of origin that has yet to be determined (eg, chordoid glioma). Other neoplasms involving the ventricular system include central neurocytoma, subependymal giant cell tumor, meningioma, rosette-forming glioneuronal tumor, and metastases. The differential diagnosis for intraventricular neoplasms can be broad, and many of them have similar patterns of signal intensity and contrast enhancement at imaging. However, the location of the lesion in the ventricular system-along with knowledge of the patient's age, gender, and underlying conditions-will help narrow the differential diagnosis.
    Radiographics 01/2013; 33(1):21-43. DOI:10.1148/rg.331125192 · 2.73 Impact Factor